Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01971463 · ClinicalTrials.gov registry record · Phase 2
Bolus of Saline in Stroke
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT01971463: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT01971463 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01971463, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study is a non-randomized, Phase 2 clinical trial designed to assess optical cerebral blood flow (CBF) response to bolus normal saline. Subjects will have had an ischemic stroke within 96 hours of enrollment. The study intervention will be a one hour monitoring session. There will be a 15 minute baseline measurement period, followed by intravenous administration of 500cc of 0.9% NaCl over 30 minutes, and finally 15 minutes of monitoring post-bolus. All study measurements will cease after 1 hour. Subjects will be followed during their hospitalization for 7 days or until discharge, whichever is sooner, to monitor for adverse events and to collect clinical information.
Interventions
- OTHER Normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2013-10 |
| Est. Completion | 2019-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01971463
The ClinicalTrials.gov registry entry for NCT01971463 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Normal saline is the first listed.
NCT01971463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01971463 about?
NCT01971463 is a clinical study titled "Bolus of Saline in Stroke". This study is a non-randomized, Phase 2 clinical trial designed to assess optical cerebral blood flow (CBF) response to bolus normal saline. Subjects will have had an ischemic stroke within 96 hours of enrollment. The study intervention will be a one hour monitoring session. There will be a 15 minut...
What is the current status of trial NCT01971463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2013-10. Estimated completion is 2019-09.
What interventions are being tested in trial NCT01971463?
The interventions under investigation include: Normal saline (OTHER).
Who is sponsoring clinical trial NCT01971463?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.